Pr T. Etrych (Academy of Science, Pragues) 2018- Evaluation de nouveaux polymères de HPMA pour le recouvrement de nanoparticules

Dr B. Bahloul (Univ. Monastir, Tunisie) 2012- Conception et formulation d’émulsions multiples

T Kral, M. Hof Heyrovsky Inst., Prague –

T Univ Material Sci, Corée

S Antimisiaris Patras, Grèce –

SG. Granados, M. Alfaro Guanajuato, Mexique

J.S. Thomann,  Luxembourg (Institute of Science and Technology)

Pr T. Teesalu (University of Tartu) 2020- Identification and validation of new cell and organ-addressed shuttles

Pr U. Langel (University of Stockholm) 2019- Identification and validation of new nucleus addressed shuttles.

Dr L. Simon-Gracia (University of Tartu) 2020– In vivo an in vitro validation of new tumor penetrating peptides.

Pr. G. Marin (Universidad de La Plata, Argentina) 2018– Im vivo validation of new cell penetrating and interfering peptides against breast cancer

Prof. G. Housley (UNSW, Sydney, Australie) 2015 – Improving the Performance of Cochlear Implants Using a pFAR Plasmid Encoding the Neurotrophic Factors BDNF and NT3 – Ongoing Phase I/II Clinical TrialCINGT (https://www.facebook.com/watch/?v=3341989752711664).

Prof. G. Thumann (Hôpitaux Universitaires de Genève, Genève, Suisse) 2012 –New Therapeutic Approaches for Age-Related Macular Degeneration (Atrophic and Exudative Forms) – Preparation for a Phase I/II Clinical Trial

Dr S. Johnen (Uniklinik RWTH Aachen, Allemagne) 2012 – Non-viral Gene Therapy for the Exudative Form of AMD

Prof. Z. Izsvák (Max Delbrück Center, Berlin, Allemagne) 2010 – Use of the Sleeping Beauty transposon and the pFAR miniplasmid for transgenic insertion approaches into the genomes of eukaryotic cells

Prof. Z. Ivics (Paul-Ehrlich-Institut, Langen, Allemagne) 2012 –Analysis of transposon integration sites following transfection of eukaryotic cells using the pFAR miniplasmid and the Sleeping Beauty transposon

Prof. M. Hudececk (Universität Würzburg, Allemagne) 2016 – Immunotherapy: Use of pFAR plasmids for the production of CAR-T cells

Dr S. Agasti (Jawaharlal Nerhu Center for Advanced Scientific Research) 2018- Chemical Nose strategy for sensing

Dr. A. Sobczyk (Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse) 2021 –pFAR mini plasmids: Immunotherapy and Bioproduction

Dr. T.Lehto – Associate Professor in Molecular Biomedicine, Principal Investigator, University of Tartu:Sujet : Placental delivery of splice switching oligonucleotides

Dr. B. Conti Full Professor University of Pavia – Strategies for Developing protective Biomaterials

Prof. H.Labouta,Scientist and Assistant Professor, Keenan Research Centre for Biomedical Science

Leslie Dan Faculty of Pharmacy, Institute of Biomedical Engineering, University of Toronto

Dr Julio Alonso-Padilla et Joaquim Gascon, CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Espagne.